Literature DB >> 35147852

An intronic GNAO1 variant leading to in-frame insertion cause movement disorder controlled by deep brain stimulation.

Sachiko Miyamoto1, Mitsuko Nakashima1, Shinobu Fukumura2, Satoko Kumada3, Hirotomo Saitsu4.   

Abstract

GNAO1 variants are associated with a wide range of neurodevelopmental disorders including epileptic encephalopathies and movement disorders. It has been reported that some GNAO1 variants are associated with movement disorders, and the 207-246 amino acid region was proposed as a mutational hotspot. Here, we report an intronic variant (NM_020988.3:c.724-8G>A) in GNAO1 in a Japanese girl who showed mild developmental delay and movement disorders including dystonia and myoclonus. Her movement disorders were improved by deep brain stimulation treatment as previously reported. This variant has been recurrently reported in four patients and was transmitted from her mother who possessed the variant as low-prevalent mosaicism. Using RNA extracted from lymphoblastoid cells derived from the patient, we demonstrated that the variant caused abnormal splicing of in-frame 6-bp intronic retention, leading to 2 amino acid insertion (p.Thr241_Asn242insProGln). Immunoblotting and immunostaining using WT and mutant GNAO1 vectors showed no significant differences in protein expression levels, but the cellular localization pattern of this mutant was partially shifted to the cytoplasm whereas WT was exclusively localized in the cellular membrane. Our report first clarified abnormal splicing and resulting mutant protein caused by the c.724-8G>A variant.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Deep brain stimulation; GNAO1; Hyperkinetic involuntary movements; Intronic variant; Parental mosaicism

Mesh:

Substances:

Year:  2022        PMID: 35147852     DOI: 10.1007/s10048-022-00686-5

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  20 in total

1.  De Novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy.

Authors:  Kazuyuki Nakamura; Hirofumi Kodera; Tenpei Akita; Masaaki Shiina; Mitsuhiro Kato; Hideki Hoshino; Hiroshi Terashima; Hitoshi Osaka; Shinichi Nakamura; Jun Tohyama; Tatsuro Kumada; Tomonori Furukawa; Satomi Iwata; Takashi Shiihara; Masaya Kubota; Satoko Miyatake; Eriko Koshimizu; Kiyomi Nishiyama; Mitsuko Nakashima; Yoshinori Tsurusaki; Noriko Miyake; Kiyoshi Hayasaka; Kazuhiro Ogata; Atsuo Fukuda; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Am J Hum Genet       Date:  2013-08-29       Impact factor: 11.025

2.  Golgi-Resident Gαo Promotes Protrusive Membrane Dynamics.

Authors:  Gonzalo P Solis; Oleksii Bilousov; Alexey Koval; Anne-Marie Lüchtenborg; Chen Lin; Vladimir L Katanaev
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

3.  Go, a guanine nucleotide-binding protein: immunohistochemical localization in rat brain resembles distribution of second messenger systems.

Authors:  P F Worley; J M Baraban; C Van Dop; E J Neer; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus.

Authors:  A L Benabid; P Pollak; C Gervason; D Hoffmann; D M Gao; M Hommel; J E Perret; J de Rougemont
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

5.  Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region.

Authors:  McKenna Kelly; Meredith Park; Ivana Mihalek; Anne Rochtus; Marie Gramm; Eduardo Pérez-Palma; Erika Takle Axeen; Christina Y Hung; Heather Olson; Lindsay Swanson; Irina Anselm; Lauren C Briere; Frances A High; David A Sweetser; Saima Kayani; Molly Snyder; Sophie Calvert; Ingrid E Scheffer; Edward Yang; Jeff L Waugh; Dennis Lal; Olaf Bodamer; Annapurna Poduri
Journal:  Epilepsia       Date:  2019-01-25       Impact factor: 5.864

6.  Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesia.

Authors:  Anne Koy; Sebahattin Cirak; Victoria Gonzalez; Kerstin Becker; Thomas Roujeau; Christophe Milesi; Julien Baleine; Gilles Cambonie; Alain Boularan; Frederic Greco; Pierre-Francois Perrigault; Claude Cances; Nathalie Dorison; Diane Doummar; Agathe Roubertie; Christophe Beroud; Friederike Körber; Burkhard Stüve; Stephan Waltz; Cyril Mignot; Caroline Nava; Mohammad Maarouf; Philippe Coubes; Laura Cif
Journal:  J Neurol Sci       Date:  2018-05-22       Impact factor: 3.181

7.  Movement disorder in GNAO1 encephalopathy associated with gain-of-function mutations.

Authors:  Huijie Feng; Benita Sjögren; Behirda Karaj; Vincent Shaw; Aysegul Gezer; Richard R Neubig
Journal:  Neurology       Date:  2017-07-26       Impact factor: 9.910

8.  GNAO1 encephalopathy: Broadening the phenotype and evaluating treatment and outcome.

Authors:  Federica Rachele Danti; Serena Galosi; Marta Romani; Martino Montomoli; Keren J Carss; F Lucy Raymond; Elena Parrini; Claudia Bianchini; Tony McShane; Russell C Dale; Shekeeb S Mohammad; Ubaid Shah; Neil Mahant; Joanne Ng; Amy McTague; Rajib Samanta; Gayatri Vadlamani; Enza Maria Valente; Vincenzo Leuzzi; Manju A Kurian; Renzo Guerrini
Journal:  Neurol Genet       Date:  2017-03-21

Review 9.  Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms.

Authors:  Lucia Abela; Manju A Kurian
Journal:  J Inherit Metab Dis       Date:  2018-06-13       Impact factor: 4.982

10.  Gαo is a major determinant of cAMP signaling in the pathophysiology of movement disorders.

Authors:  Brian S Muntean; Ikuo Masuho; Maria Dao; Laurie P Sutton; Stefano Zucca; Hideki Iwamoto; Dipak N Patil; Dandan Wang; Lutz Birnbaumer; Randy D Blakely; Brock Grill; Kirill A Martemyanov
Journal:  Cell Rep       Date:  2021-02-02       Impact factor: 9.423

View more
  3 in total

1.  DBS emergency surgery for treatment of dystonic storm associated with rhabdomyolysis and acute colitis in DYT-GNAO1.

Authors:  Hind Chaib; Jan-Christoph Schoene-Bake; Assel Saryyeva; Thomas Jack; Hans Hartmann; Joachim K Krauss
Journal:  Childs Nerv Syst       Date:  2022-06-20       Impact factor: 1.532

2.  Gonadal mosaicism in GNAO1 causing neurodevelopmental disorder with involuntary movements; two additional variants.

Authors:  Zainab Al Masseri; Moeenaldeen AlSayed
Journal:  Mol Genet Metab Rep       Date:  2022-04-18

3.  Highlighting the Dystonic Phenotype Related to GNAO1.

Authors:  Thomas Wirth; Giacomo Garone; Manju A Kurian; Amélie Piton; Francisca Millan; Aida Telegrafi; Nathalie Drouot; Gabrielle Rudolf; Jamel Chelly; Warren Marks; Lydie Burglen; Diane Demailly; Phillipe Coubes; Mayte Castro-Jimenez; Sylvie Joriot; Jamal Ghoumid; Jérémie Belin; Jean-Marc Faucheux; Lubov Blumkin; Mariam Hull; Mered Parnes; Claudia Ravelli; Gaëtan Poulen; Nadège Calmels; Andrea H Nemeth; Martin Smith; Angela Barnicoat; Claire Ewenczyk; Aurélie Méneret; Emmanuel Roze; Boris Keren; Cyril Mignot; Christophe Beroud; Fernando Acosta; Catherine Nowak; William G Wilson; Dora Steel; Alessandro Capuano; Marie Vidailhet; Jean-Pierre Lin; Christine Tranchant; Laura Cif; Diane Doummar; Mathieu Anheim
Journal:  Mov Disord       Date:  2022-06-20       Impact factor: 9.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.